Barcelona – Pittsburgh
Aquesta conferència s’ha convertit en una referència en el camp de la demència. Al maig de 2026, BcnPit tornarà a sorgir com un valuós fòrum on professionals de tot el món poden connectar-se i compartir el seu treball i perspectives sobre la demència.
Aquesta conferència d’alta qualitat reunirà panelistes de reconegut prestigi científic internacional i crearà un espai interactiu amb l’objectiu final d’ajudar a les persones afectades i a les seves famílies.
Ens veiem a Barcelona-Pittsburgh 2026!
Consulta els ponents d’altres edicions
At Ace, he design CTs and other global CT from pharmaceutical companies, participate in international boards to improve CT management and promote research projects to validate novel biomarkers for an early detection of the disease and find novel therapeutical approaches.
Xavier Morató, PhD Pharmacy Unit at AceDr. Butler research focusses on understanding the memory deficits experienced by patients with damage to the medial temporal lobes of the brain
Chris Butler, MD, PhD Clinical Senior Lecturer in Neurology at the Imperial CollegeNeurologist specialist in cognitive disorders with a broad clinical and research experience in Spain and the United States.
Marta Marquié, MD, PhD Neurologist at AceHe has more than 20 years of experience in basic, clinical and applied research in drug dependence, psychopathology and memory disorders.
Sergi Valero, PhD Head of Medical Psychology at Ace Alzheimer Center BarcelonaDr. Cano is in charge of the molecular biology unit of Ace Alzheimer Center Barcelona and her studies are related to the clinical evaluation of early biomarkers of Alzheimer’s disease.
Amanda Cano, PhD Postdoctoral researcher at AceThe main objective of his genomic research group is to understand the causes of Alzheimer’s disease and other dementias by integrating genetic, transcriptomic and proteomic data.
Agustín Ruiz, MD, PhD Chief Scientific Officer at AceDr. Boada focuses her research on the treatment of AD and related dementias, especially on the genotype and phenotype of common degenerative diseases and the design of new pharmacological and non-pharmacological treatments.
Prof. Mercè Boada, MD, PhD Chief Medical Officer at AceZONA DE PONENTS
Patrocinadors del BCNPIT
